FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4282945787> ?p ?o ?g. }

• W4282945787 endingPage "2065" @default.
• W4282945787 startingPage "2065" @default.
• W4282945787 abstract "To report the reasons for treatment discontinuation within 5 years in patients receiving intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy for neovascular age-related macular degeneration (nAMD).A retrospective case-notes review of patients commenced on anti-VEGF for nAMD who failed to complete 5 years of follow-up was undertaken. The reasons for treatment discontinuation, baseline age, baseline visual acuity (VA) in Early Treatment Diabetic Retinopathy Study (ETDRS) letters, and the VA change at the last follow-up were recorded. Age-specific all-cause mortality was calculated for deceased patients.Of the 1177 patients, 551 patients (46.8%) failed to complete the 5-year follow-up. The reasons for treatment discontinuation were death (251), early discharge due to stable disease (110), further treatment deemed futile (100), failure to attend (15), ill health (14), patient choice (7), and transfer of care (1). In 53 patients, no reason was documented. The mean baseline age of those who completed the 5-year follow-up (77.4 ± 7.8 years, 95% confidence interval (CI): 76.8-77.9) was significantly lower than those who discontinued the treatment for any reason (82 ± 7.7 years, 95% CI: 81.4-82.6) (P < 0.0001). Survival analysis showed that baseline VA was not a factor in treatment discontinuation; however, visual stability (±5 letters from baseline) was associated with treatment continuation. The age-specific all-cause mortality in deceased patients was lower than that in the general population.At 5 years, only 53% of patients remained in active care, and death was the most common reason for treatment discontinuation. Lower baseline age and VA stability during therapy were associated with treatment continuation." @default.
• W4282945787 created "2022-06-16" @default.
• W4282945787 creator A5070489336 @default.
• W4282945787 creator A5073289646 @default.
• W4282945787 creator A5089181046 @default.
• W4282945787 date "2022-01-01" @default.
• W4282945787 modified "2023-09-25" @default.
• W4282945787 title "Patterns of treatment discontinuation in patients receiving anti-vascular endothelial growth factor for neovascular age-related macular degeneration" @default.
• W4282945787 cites W1992612246 @default.
• W4282945787 cites W2004117352 @default.
• W4282945787 cites W2029718336 @default.
• W4282945787 cites W2030859223 @default.
• W4282945787 cites W2068742492 @default.
• W4282945787 cites W2079794035 @default.
• W4282945787 cites W2083043469 @default.
• W4282945787 cites W2093646832 @default.
• W4282945787 cites W2124415048 @default.
• W4282945787 cites W2160226180 @default.
• W4282945787 cites W2322467860 @default.
• W4282945787 cites W2323455961 @default.
• W4282945787 cites W2419186472 @default.
• W4282945787 cites W2509759140 @default.
• W4282945787 cites W2545751468 @default.
• W4282945787 cites W2620988129 @default.
• W4282945787 cites W2766090454 @default.
• W4282945787 cites W2801761853 @default.
• W4282945787 cites W2888464051 @default.
• W4282945787 cites W2913437590 @default.
• W4282945787 cites W2963350486 @default.
• W4282945787 cites W2979467486 @default.
• W4282945787 cites W2989989541 @default.
• W4282945787 cites W2997212676 @default.
• W4282945787 cites W3002562981 @default.
• W4282945787 cites W3008426762 @default.
• W4282945787 cites W3013512820 @default.
• W4282945787 cites W3014487234 @default.
• W4282945787 cites W3047590017 @default.
• W4282945787 cites W3089306714 @default.
• W4282945787 cites W3093144182 @default.
• W4282945787 cites W3110220146 @default.
• W4282945787 cites W633153563 @default.
• W4282945787 doi "https://doi.org/10.4103/ijo.ijo_3066_21" @default.
• W4282945787 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35647983" @default.
• W4282945787 hasPublicationYear "2022" @default.
• W4282945787 type Work @default.
• W4282945787 citedByCount "3" @default.
• W4282945787 countsByYear W42829457872022 @default.
• W4282945787 countsByYear W42829457872023 @default.
• W4282945787 crossrefType "journal-article" @default.
• W4282945787 hasAuthorship W4282945787A5070489336 @default.
• W4282945787 hasAuthorship W4282945787A5073289646 @default.
• W4282945787 hasAuthorship W4282945787A5089181046 @default.
• W4282945787 hasBestOaLocation W42829457871 @default.
• W4282945787 hasConcept C118487528 @default.
• W4282945787 hasConcept C126322002 @default.
• W4282945787 hasConcept C134018914 @default.
• W4282945787 hasConcept C141071460 @default.
• W4282945787 hasConcept C167135981 @default.
• W4282945787 hasConcept C187212893 @default.
• W4282945787 hasConcept C2776403814 @default.
• W4282945787 hasConcept C2776694085 @default.
• W4282945787 hasConcept C2777802072 @default.
• W4282945787 hasConcept C2778257484 @default.
• W4282945787 hasConcept C2778715236 @default.
• W4282945787 hasConcept C2779829184 @default.
• W4282945787 hasConcept C2781100027 @default.
• W4282945787 hasConcept C2908647359 @default.
• W4282945787 hasConcept C555293320 @default.
• W4282945787 hasConcept C71924100 @default.
• W4282945787 hasConcept C99454951 @default.
• W4282945787 hasConceptScore W4282945787C118487528 @default.
• W4282945787 hasConceptScore W4282945787C126322002 @default.
• W4282945787 hasConceptScore W4282945787C134018914 @default.
• W4282945787 hasConceptScore W4282945787C141071460 @default.
• W4282945787 hasConceptScore W4282945787C167135981 @default.
• W4282945787 hasConceptScore W4282945787C187212893 @default.
• W4282945787 hasConceptScore W4282945787C2776403814 @default.
• W4282945787 hasConceptScore W4282945787C2776694085 @default.
• W4282945787 hasConceptScore W4282945787C2777802072 @default.
• W4282945787 hasConceptScore W4282945787C2778257484 @default.
• W4282945787 hasConceptScore W4282945787C2778715236 @default.
• W4282945787 hasConceptScore W4282945787C2779829184 @default.
• W4282945787 hasConceptScore W4282945787C2781100027 @default.
• W4282945787 hasConceptScore W4282945787C2908647359 @default.
• W4282945787 hasConceptScore W4282945787C555293320 @default.
• W4282945787 hasConceptScore W4282945787C71924100 @default.
• W4282945787 hasConceptScore W4282945787C99454951 @default.
• W4282945787 hasIssue "6" @default.
• W4282945787 hasLocation W42829457871 @default.
• W4282945787 hasLocation W42829457872 @default.
• W4282945787 hasLocation W42829457873 @default.
• W4282945787 hasLocation W42829457874 @default.
• W4282945787 hasOpenAccess W4282945787 @default.
• W4282945787 hasPrimaryLocation W42829457871 @default.
• W4282945787 hasRelatedWork W1995044506 @default.
• W4282945787 hasRelatedWork W2068871928 @default.
• W4282945787 hasRelatedWork W2121621777 @default.
• W4282945787 hasRelatedWork W2159235953 @default.

• next